WAM
ARNA

Wolverine Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Wolverine Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,200
Closed -$37K – 1388
2016
Q2 		$37K Buy
+2,200
New +$39.3K ﹤0.01% 1061
2016
Q1 		– Sell
-1
Closed -$1K – 1715
2015
Q4 		$1K Buy
+1
New +$20 ﹤0.01% 1648
2014
Q4 		– Sell
-106
Closed -$116K – 2584
2014
Q3 		$116K Buy
+106
New +$4.73K ﹤0.01% 1256
2014
Q1 		– Sell
-133
Closed -$205K – 2872
2013
Q4 		$205K Buy
133
+100
+303% +$5.23K ﹤0.01% 1144
2013
Q3 		$89K Sell
33
-23
-41% -$1.54K ﹤0.01% 1512
2013
Q2 		$11K Buy
+56
New +$4.57K ﹤0.01% 2203

Wolverine Asset Management's ARNA Position: Q1 2022 in Review

Wolverine Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,880 shares — an estimated $918K sold.

Wolverine Asset Management first reported a position in ARNA in Q2 2013 and held it in 11 quarters. The position peaked at $918K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Wolverine Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 9,880 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $918K.
  • Wolverine Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Wolverine Asset Management's Arena Pharmaceuticals Inc position peaked at $918K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Wolverine Asset Management's 13F filing for Q1 2022, filed 4 May 2022.